Guideline Profile : Wet age-related macular degeneration
You are here : Home > Formulary Search > Guideline Profile : Wet age-related macular degeneration
Documentation
Guidelines (National)
Drugs
Below are listed all drugs that are used to treat Wet age-related macular degeneration.
Committee Recommendations (1)
APC agreed to adopt the NHSE pathway for wet AMD
Guideline Profile
Indication :
Wet age-related macular degeneration
Keywords :
Aflibercept, Ranibizumab, biosimilar, Faricimab, Brolucizumab, Bevacizumab Gamma, wamd, wet AMD
Brand Names Include :
Eylea, Ongavia, Vabysmo, Ximluci, Byooviz, Rimmyrah, Lytenava
Important Information :
Latest Additions Date From :
06 Aug 2025
Latest Additions Date To :
Supporting Documents :
1